IperionX has completed an AU$20 million placement to scale up titanium production

IperionX Limited (ASX: IPX), a pioneer in the creation of sustainable and circular titanium metal, reported that it has secured firm commitments for the placement of 20 million new fully paid ordinary shares to institutional, knowledgeable, and professional investors at an issue price of AU$1.00 per share, to raise gross proceeds of AU$20 million before costs.The issue price of AU$1.00 per New Share represents a 5% discount to the 10-day VWAP of AU$1.05.

Proceeds from the Placement will be used to advance and scale its patented titanium technologies, progress permitting and feasibility studies at the Titan Critical Mineral Project and for general corporate purposes.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com